Malignant Urethral Neoplasm — Trials

Malignant Urethral Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05899361	A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest	recruiting	N/A	10	Dana-Farber Cancer InstituteOTHER	1	Oct 24, 2023	clinicaltrials
NCT02643043	UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch	completed	N/A	219	Matthew Milowsky, MDOTHER	1	Sep 29, 2023	clinicaltrials